|
Jan 2
|
Amphastar Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
|
|
Jan 1
|
Amphastar Pharmaceuticals (AMPH) Is Up 1.53% in One Week: What You Should Know
|
|
Dec 30
|
Here's Why We Think Amphastar Pharmaceuticals (NASDAQ:AMPH) Is Well Worth Watching
|
|
Dec 27
|
Are Medical Stocks Lagging Arch Therapeutics (ARTH) This Year?
|
|
Dec 27
|
Wall Street Analysts Think Amphastar (AMPH) Is a Good Investment: Is It?
|
|
Dec 27
|
The Zacks Analyst Blog Highlights Amphastar Pharmaceuticals, Journey Medical, Centessa Pharmaceuticals and Aquestive Therapeutics
|
|
Dec 27
|
Zacks.com featured highlights include Amphastar Pharmaceuticals, Shift4 Payments, Beacon Roofing Supply, Hooker Furnishings and Hilltop Holdings
|
|
Dec 26
|
What Awaits These 4 Drug Stocks That More Than Doubled in 2023?
|
|
Dec 26
|
5 Good Opportunities on Relative Price Strength Strategy
|
|
Dec 21
|
Will Eli Lilly's Emergency Diabetes Drug Give Amphastar Wings?
|
|
Dec 8
|
3 Reasons Why Growth Investors Shouldn't Overlook Amphastar (AMPH)
|
|
Dec 8
|
Is Atossa Genetics (ATOS) Outperforming Other Medical Stocks This Year?
|
|
Dec 6
|
Zacks.com featured highlights Abercrombie & Fitch, Amphastar and NetEase
|
|
Dec 5
|
Are You Looking for a Top Momentum Pick? Why Amphastar Pharmaceuticals (AMPH) is a Great Choice
|
|
Dec 4
|
Amphastar, Stock Of The Day, Breaks Out As It Sees Upside From Eli Lilly Deal
|
|
Nov 30
|
This Biotech Stock Nears A Buy Point After 200% Profit Growth
|
|
Nov 29
|
Amphastar (AMPH) Is Considered a Good Investment by Brokers: Is That True?
|
|
Nov 24
|
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Delivered A Better ROE Than Its Industry
|
|
Nov 13
|
Wall Street Analysts See Amphastar (AMPH) as a Buy: Should You Invest?
|
|
Nov 10
|
Amphastar Pharmaceuticals Stock Earns Composite Rating Upgrade
|